BESSER JAMES E 4
4 · Processa Pharmaceuticals, Inc. · Filed Feb 22, 2021
Insider Transaction Report
Form 4
BESSER JAMES E
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2021-02-19$11.20/sh−3,000$33,600→ 1,117,000 total - Sale
Common Stock, $0.01 par value
2021-02-18$11.35/sh−5,000$56,750→ 1,120,000 total - Sale
Common Stock, $0.01 par value
2021-02-22$11.56/sh−20,929$241,939→ 1,096,071 total
Holdings
- 405,000(indirect: See footnote)
Common Stock, $0.01 par value
Footnotes (2)
- [F1]These securities are directly owned by Manchester Explorer, L.P. and JEB Partners, L.P. These securities are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P.; these securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC.
- [F2]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.